Drug recall · July 8, 2026
Synjardy XR Tablets recall
Why: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45
- Lots / codes
Lot 3244413; Exp. 12/31/2028
- Quantity
- 560 bottles
- Company
- Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT
- Distribution
- OH
- Initiated
- June 12, 2026 · Voluntary: Firm initiated
- Classified
- June 30, 2026
- Reported
- July 8, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Synjardy
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.